JETLAG
Conditions
Interventions
administration of liposomal lactoferrin (270 mg lactoferrin/day) for 21 days
Sponsors
Sunstar Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Persons accompanying overseas travelers more than once during the survey period Persons who have experienced jet lag or travel fatigue and show these symptoms relatively frequently
Exclusion criteria
Exclusion criteria: Those who consumed food/supplements containing at least 100 mg of lactoferrin within 2 weeks before the start of the study. Those who have a history of allergic reactions to the test foods (milk, soybeans) Persons who are unable to follow the procedures of various surveys conducted during the survey period (e.g. filling out various survey forms, wearing an Actigraph, etc.) Persons judged to be unsuitable as monitors based on the answers to the preliminary questionnaire Those who are participating in other clinical studies at the start of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Actigraphic assessment (Sleep Latency, Total Counts, Sleep Efficiency, Total Minutes in Bed, Total Sleep Time, Wake After Sleep Onset, Number of Awakenings, Average Awakening Length) | — |
Secondary
| Measure | Time frame |
|---|---|
| Liverpool Jetlag Questionnaire, Oguri-Shirakawa-Azumi Sleep Inventory, Middle-Aged version (OSA-MA) | — |
Countries
Japan
Contacts
Public ContactShoko Uesaki
Sunstar Inc. R&D Department
Outcome results
None listed